nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—PPARG—urinary bladder cancer	0.724	1	CbGaD
Glipizide—CYP3A4—Thiotepa—urinary bladder cancer	0.0181	0.402	CbGbCtD
Glipizide—ABCC8—penis—urinary bladder cancer	0.0149	0.276	CbGeAlD
Glipizide—CYP2C9—Fluorouracil—urinary bladder cancer	0.0101	0.224	CbGbCtD
Glipizide—CYP2C9—Cisplatin—urinary bladder cancer	0.00857	0.191	CbGbCtD
Glipizide—CYP3A4—Etoposide—urinary bladder cancer	0.00489	0.109	CbGbCtD
Glipizide—CYP2C9—urine—urinary bladder cancer	0.00442	0.0822	CbGeAlD
Glipizide—ABCC8—prostate gland—urinary bladder cancer	0.00355	0.066	CbGeAlD
Glipizide—CYP3A4—urine—urinary bladder cancer	0.00337	0.0627	CbGeAlD
Glipizide—CYP3A4—Doxorubicin—urinary bladder cancer	0.00334	0.0743	CbGbCtD
Glipizide—PPARG—Teniposide—Etoposide—urinary bladder cancer	0.00327	1	CbGdCrCtD
Glipizide—ABCC8—seminal vesicle—urinary bladder cancer	0.003	0.0558	CbGeAlD
Glipizide—PPARG—prostate gland—urinary bladder cancer	0.00271	0.0504	CbGeAlD
Glipizide—ABCC8—smooth muscle tissue—urinary bladder cancer	0.00251	0.0467	CbGeAlD
Glipizide—ABCC8—renal system—urinary bladder cancer	0.00242	0.045	CbGeAlD
Glipizide—KCNJ11—female reproductive system—urinary bladder cancer	0.0021	0.0391	CbGeAlD
Glipizide—PPARG—epithelium—urinary bladder cancer	0.00199	0.037	CbGeAlD
Glipizide—PPARG—smooth muscle tissue—urinary bladder cancer	0.00192	0.0357	CbGeAlD
Glipizide—PPARG—renal system—urinary bladder cancer	0.00185	0.0343	CbGeAlD
Glipizide—PPARG—urethra—urinary bladder cancer	0.00181	0.0337	CbGeAlD
Glipizide—PPARG—female reproductive system—urinary bladder cancer	0.00148	0.0275	CbGeAlD
Glipizide—PPARG—vagina—urinary bladder cancer	0.00134	0.0249	CbGeAlD
Glipizide—KCNJ11—lymph node—urinary bladder cancer	0.00123	0.0229	CbGeAlD
Glipizide—CYP2C9—female reproductive system—urinary bladder cancer	0.000866	0.0161	CbGeAlD
Glipizide—PPARG—lymph node—urinary bladder cancer	0.000865	0.0161	CbGeAlD
Glipizide—CYP3A4—renal system—urinary bladder cancer	0.000824	0.0153	CbGeAlD
Glipizide—CYP3A4—female reproductive system—urinary bladder cancer	0.00066	0.0123	CbGeAlD
Glipizide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000233	0.00173	CcSEcCtD
Glipizide—Pancytopenia—Methotrexate—urinary bladder cancer	0.000232	0.00173	CcSEcCtD
Glipizide—Asthenia—Thiotepa—urinary bladder cancer	0.000232	0.00173	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000231	0.00172	CcSEcCtD
Glipizide—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000231	0.00172	CcSEcCtD
Glipizide—Dysuria—Methotrexate—urinary bladder cancer	0.000229	0.0017	CcSEcCtD
Glipizide—Pruritus—Thiotepa—urinary bladder cancer	0.000229	0.0017	CcSEcCtD
Glipizide—Pain—Fluorouracil—urinary bladder cancer	0.000229	0.0017	CcSEcCtD
Glipizide—Paraesthesia—Cisplatin—urinary bladder cancer	0.000228	0.00169	CcSEcCtD
Glipizide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000227	0.00169	CcSEcCtD
Glipizide—Dyspnoea—Cisplatin—urinary bladder cancer	0.000226	0.00168	CcSEcCtD
Glipizide—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000225	0.00167	CcSEcCtD
Glipizide—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000224	0.00167	CcSEcCtD
Glipizide—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000224	0.00167	CcSEcCtD
Glipizide—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000223	0.00166	CcSEcCtD
Glipizide—Anorexia—Etoposide—urinary bladder cancer	0.000221	0.00165	CcSEcCtD
Glipizide—Diarrhoea—Thiotepa—urinary bladder cancer	0.000221	0.00165	CcSEcCtD
Glipizide—Decreased appetite—Cisplatin—urinary bladder cancer	0.00022	0.00164	CcSEcCtD
Glipizide—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00022	0.00164	CcSEcCtD
Glipizide—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000219	0.00163	CcSEcCtD
Glipizide—Drowsiness—Methotrexate—urinary bladder cancer	0.000218	0.00162	CcSEcCtD
Glipizide—Pancytopenia—Epirubicin—urinary bladder cancer	0.000218	0.00162	CcSEcCtD
Glipizide—Pain—Cisplatin—urinary bladder cancer	0.000217	0.00161	CcSEcCtD
Glipizide—Dysuria—Epirubicin—urinary bladder cancer	0.000214	0.00159	CcSEcCtD
Glipizide—Dizziness—Thiotepa—urinary bladder cancer	0.000214	0.00159	CcSEcCtD
Glipizide—Urticaria—Fluorouracil—urinary bladder cancer	0.000213	0.00158	CcSEcCtD
Glipizide—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000212	0.00158	CcSEcCtD
Glipizide—Sweating—Methotrexate—urinary bladder cancer	0.000209	0.00156	CcSEcCtD
Glipizide—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000209	0.00156	CcSEcCtD
Glipizide—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000209	0.00155	CcSEcCtD
Glipizide—Paraesthesia—Etoposide—urinary bladder cancer	0.000209	0.00155	CcSEcCtD
Glipizide—Dyspnoea—Etoposide—urinary bladder cancer	0.000207	0.00154	CcSEcCtD
Glipizide—Somnolence—Etoposide—urinary bladder cancer	0.000207	0.00154	CcSEcCtD
Glipizide—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000206	0.00154	CcSEcCtD
Glipizide—Vomiting—Thiotepa—urinary bladder cancer	0.000206	0.00153	CcSEcCtD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—CREBBP—urinary bladder cancer	0.000205	0.00511	CbGpPWpGaD
Glipizide—Drowsiness—Epirubicin—urinary bladder cancer	0.000204	0.00152	CcSEcCtD
Glipizide—Rash—Thiotepa—urinary bladder cancer	0.000204	0.00152	CcSEcCtD
Glipizide—Dermatitis—Thiotepa—urinary bladder cancer	0.000204	0.00152	CcSEcCtD
Glipizide—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000204	0.00152	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—urinary bladder cancer	0.000203	0.00508	CbGpPWpGaD
Glipizide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—urinary bladder cancer	0.000203	0.00506	CbGpPWpGaD
Glipizide—Headache—Thiotepa—urinary bladder cancer	0.000203	0.00151	CcSEcCtD
Glipizide—Decreased appetite—Etoposide—urinary bladder cancer	0.000202	0.0015	CcSEcCtD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000201	0.00503	CbGpPWpGaD
Glipizide—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000201	0.0015	CcSEcCtD
Glipizide—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000201	0.00501	CbGpPWpGaD
Glipizide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000201	0.00149	CcSEcCtD
Glipizide—Jaundice—Epirubicin—urinary bladder cancer	0.000199	0.00148	CcSEcCtD
Glipizide—Pain—Etoposide—urinary bladder cancer	0.000199	0.00148	CcSEcCtD
Glipizide—Constipation—Etoposide—urinary bladder cancer	0.000199	0.00148	CcSEcCtD
Glipizide—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000199	0.00148	CcSEcCtD
Glipizide—Dysuria—Doxorubicin—urinary bladder cancer	0.000198	0.00147	CcSEcCtD
Glipizide—ABCC8—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000197	0.00492	CbGpPWpGaD
Glipizide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000197	0.00147	CcSEcCtD
Glipizide—CYP2C9—Biological oxidations—GSTO2—urinary bladder cancer	0.000197	0.00492	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—NAT1—urinary bladder cancer	0.000197	0.00492	CbGpPWpGaD
Glipizide—Hepatitis—Methotrexate—urinary bladder cancer	0.000196	0.00146	CcSEcCtD
Glipizide—Sweating—Epirubicin—urinary bladder cancer	0.000196	0.00146	CcSEcCtD
Glipizide—Asthenia—Gemcitabine—urinary bladder cancer	0.000195	0.00145	CcSEcCtD
Glipizide—Pharyngitis—Methotrexate—urinary bladder cancer	0.000194	0.00145	CcSEcCtD
Glipizide—CYP2C9—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000194	0.00485	CbGpPWpGaD
Glipizide—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000193	0.00144	CcSEcCtD
Glipizide—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000193	0.00144	CcSEcCtD
Glipizide—Pruritus—Gemcitabine—urinary bladder cancer	0.000193	0.00143	CcSEcCtD
Glipizide—Nausea—Thiotepa—urinary bladder cancer	0.000192	0.00143	CcSEcCtD
Glipizide—PPARG—Wnt Signaling Pathway Netpath—CCND1—urinary bladder cancer	0.000192	0.0048	CbGpPWpGaD
Glipizide—Feeling abnormal—Etoposide—urinary bladder cancer	0.000191	0.00142	CcSEcCtD
Glipizide—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000191	0.00142	CcSEcCtD
Glipizide—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00019	0.00141	CcSEcCtD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—CREBBP—urinary bladder cancer	0.00019	0.00474	CbGpPWpGaD
Glipizide—Pruritus—Fluorouracil—urinary bladder cancer	0.000189	0.00141	CcSEcCtD
Glipizide—Drowsiness—Doxorubicin—urinary bladder cancer	0.000189	0.00141	CcSEcCtD
Glipizide—Visual impairment—Methotrexate—urinary bladder cancer	0.000189	0.0014	CcSEcCtD
Glipizide—PPARG—Regulation of retinoblastoma protein—CDKN2A—urinary bladder cancer	0.000188	0.00469	CbGpPWpGaD
Glipizide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000187	0.00139	CcSEcCtD
Glipizide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000186	0.00139	CcSEcCtD
Glipizide—Urticaria—Etoposide—urinary bladder cancer	0.000185	0.00137	CcSEcCtD
Glipizide—Jaundice—Doxorubicin—urinary bladder cancer	0.000184	0.00137	CcSEcCtD
Glipizide—Rhinitis—Epirubicin—urinary bladder cancer	0.000184	0.00137	CcSEcCtD
Glipizide—Abdominal pain—Etoposide—urinary bladder cancer	0.000184	0.00137	CcSEcCtD
Glipizide—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000184	0.00137	CcSEcCtD
Glipizide—Hepatitis—Epirubicin—urinary bladder cancer	0.000183	0.00136	CcSEcCtD
Glipizide—Eye disorder—Methotrexate—urinary bladder cancer	0.000183	0.00136	CcSEcCtD
Glipizide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000183	0.00136	CcSEcCtD
Glipizide—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000182	0.00136	CcSEcCtD
Glipizide—Asthenia—Cisplatin—urinary bladder cancer	0.000182	0.00135	CcSEcCtD
Glipizide—Pharyngitis—Epirubicin—urinary bladder cancer	0.000182	0.00135	CcSEcCtD
Glipizide—PPARG—Adipogenesis—NCOR1—urinary bladder cancer	0.000181	0.00453	CbGpPWpGaD
Glipizide—Sweating—Doxorubicin—urinary bladder cancer	0.000181	0.00135	CcSEcCtD
Glipizide—CYP2C9—Biological oxidations—UGT2B7—urinary bladder cancer	0.00018	0.0045	CbGpPWpGaD
Glipizide—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000179	0.00133	CcSEcCtD
Glipizide—CYP2C9—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000178	0.00444	CbGpPWpGaD
Glipizide—Dizziness—Fluorouracil—urinary bladder cancer	0.000177	0.00132	CcSEcCtD
Glipizide—Visual impairment—Epirubicin—urinary bladder cancer	0.000177	0.00131	CcSEcCtD
Glipizide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000176	0.00131	CcSEcCtD
Glipizide—Chills—Methotrexate—urinary bladder cancer	0.000176	0.00131	CcSEcCtD
Glipizide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000174	0.00129	CcSEcCtD
Glipizide—Vomiting—Gemcitabine—urinary bladder cancer	0.000173	0.00129	CcSEcCtD
Glipizide—Rash—Gemcitabine—urinary bladder cancer	0.000172	0.00128	CcSEcCtD
Glipizide—Dermatitis—Gemcitabine—urinary bladder cancer	0.000171	0.00128	CcSEcCtD
Glipizide—Eye disorder—Epirubicin—urinary bladder cancer	0.000171	0.00127	CcSEcCtD
Glipizide—Hypersensitivity—Etoposide—urinary bladder cancer	0.000171	0.00127	CcSEcCtD
Glipizide—Erythema—Methotrexate—urinary bladder cancer	0.000171	0.00127	CcSEcCtD
Glipizide—Headache—Gemcitabine—urinary bladder cancer	0.00017	0.00127	CcSEcCtD
Glipizide—Flushing—Epirubicin—urinary bladder cancer	0.00017	0.00127	CcSEcCtD
Glipizide—Vomiting—Fluorouracil—urinary bladder cancer	0.00017	0.00127	CcSEcCtD
Glipizide—Rhinitis—Doxorubicin—urinary bladder cancer	0.00017	0.00127	CcSEcCtD
Glipizide—Hepatitis—Doxorubicin—urinary bladder cancer	0.00017	0.00126	CcSEcCtD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000169	0.00423	CbGpPWpGaD
Glipizide—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000169	0.00126	CcSEcCtD
Glipizide—Rash—Fluorouracil—urinary bladder cancer	0.000169	0.00126	CcSEcCtD
Glipizide—Dermatitis—Fluorouracil—urinary bladder cancer	0.000169	0.00125	CcSEcCtD
Glipizide—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000168	0.00125	CcSEcCtD
Glipizide—Headache—Fluorouracil—urinary bladder cancer	0.000168	0.00125	CcSEcCtD
Glipizide—Asthenia—Etoposide—urinary bladder cancer	0.000167	0.00124	CcSEcCtD
Glipizide—PPARG—Developmental Biology—CNTN2—urinary bladder cancer	0.000166	0.00416	CbGpPWpGaD
Glipizide—Chills—Epirubicin—urinary bladder cancer	0.000164	0.00122	CcSEcCtD
Glipizide—Pruritus—Etoposide—urinary bladder cancer	0.000164	0.00122	CcSEcCtD
Glipizide—Arrhythmia—Epirubicin—urinary bladder cancer	0.000164	0.00122	CcSEcCtD
Glipizide—Visual impairment—Doxorubicin—urinary bladder cancer	0.000163	0.00122	CcSEcCtD
Glipizide—PPARG—Adipogenesis—FAS—urinary bladder cancer	0.000162	0.00406	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP4B1—urinary bladder cancer	0.000162	0.00405	CbGpPWpGaD
Glipizide—Nausea—Gemcitabine—urinary bladder cancer	0.000162	0.0012	CcSEcCtD
Glipizide—Vomiting—Cisplatin—urinary bladder cancer	0.000161	0.0012	CcSEcCtD
Glipizide—Vision blurred—Methotrexate—urinary bladder cancer	0.000161	0.0012	CcSEcCtD
Glipizide—ABCC8—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000161	0.00401	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00016	0.004	CbGpPWpGaD
Glipizide—Rash—Cisplatin—urinary bladder cancer	0.00016	0.00119	CcSEcCtD
Glipizide—Dermatitis—Cisplatin—urinary bladder cancer	0.00016	0.00119	CcSEcCtD
Glipizide—Erythema—Epirubicin—urinary bladder cancer	0.00016	0.00119	CcSEcCtD
Glipizide—Diarrhoea—Etoposide—urinary bladder cancer	0.000159	0.00118	CcSEcCtD
Glipizide—Nausea—Fluorouracil—urinary bladder cancer	0.000159	0.00118	CcSEcCtD
Glipizide—PPARG—Regulation of retinoblastoma protein—CCND1—urinary bladder cancer	0.000159	0.00396	CbGpPWpGaD
Glipizide—Eye disorder—Doxorubicin—urinary bladder cancer	0.000159	0.00118	CcSEcCtD
Glipizide—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000158	0.00118	CcSEcCtD
Glipizide—Flushing—Doxorubicin—urinary bladder cancer	0.000157	0.00117	CcSEcCtD
Glipizide—Flatulence—Epirubicin—urinary bladder cancer	0.000157	0.00117	CcSEcCtD
Glipizide—Tension—Epirubicin—urinary bladder cancer	0.000157	0.00117	CcSEcCtD
Glipizide—Nervousness—Epirubicin—urinary bladder cancer	0.000155	0.00115	CcSEcCtD
Glipizide—PPARG—Wnt Signaling Pathway Netpath—MYC—urinary bladder cancer	0.000154	0.00385	CbGpPWpGaD
Glipizide—Malaise—Methotrexate—urinary bladder cancer	0.000154	0.00114	CcSEcCtD
Glipizide—Dizziness—Etoposide—urinary bladder cancer	0.000154	0.00114	CcSEcCtD
Glipizide—PPARG—Regulation of retinoblastoma protein—CDKN1A—urinary bladder cancer	0.000154	0.00384	CbGpPWpGaD
Glipizide—Muscle spasms—Epirubicin—urinary bladder cancer	0.000153	0.00114	CcSEcCtD
Glipizide—Vertigo—Methotrexate—urinary bladder cancer	0.000153	0.00114	CcSEcCtD
Glipizide—Leukopenia—Methotrexate—urinary bladder cancer	0.000153	0.00114	CcSEcCtD
Glipizide—Chills—Doxorubicin—urinary bladder cancer	0.000152	0.00113	CcSEcCtD
Glipizide—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000152	0.00113	CcSEcCtD
Glipizide—Nausea—Cisplatin—urinary bladder cancer	0.000151	0.00112	CcSEcCtD
Glipizide—Vision blurred—Epirubicin—urinary bladder cancer	0.00015	0.00112	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	0.000148	0.0037	CbGpPWpGaD
Glipizide—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000148	0.0011	CcSEcCtD
Glipizide—Vomiting—Etoposide—urinary bladder cancer	0.000148	0.0011	CcSEcCtD
Glipizide—Erythema—Doxorubicin—urinary bladder cancer	0.000148	0.0011	CcSEcCtD
Glipizide—Rash—Etoposide—urinary bladder cancer	0.000147	0.00109	CcSEcCtD
Glipizide—Dermatitis—Etoposide—urinary bladder cancer	0.000146	0.00109	CcSEcCtD
Glipizide—PPARG—Regulation of retinoblastoma protein—EP300—urinary bladder cancer	0.000146	0.00365	CbGpPWpGaD
Glipizide—Headache—Etoposide—urinary bladder cancer	0.000146	0.00108	CcSEcCtD
Glipizide—Flatulence—Doxorubicin—urinary bladder cancer	0.000146	0.00108	CcSEcCtD
Glipizide—Myalgia—Methotrexate—urinary bladder cancer	0.000145	0.00108	CcSEcCtD
Glipizide—Arthralgia—Methotrexate—urinary bladder cancer	0.000145	0.00108	CcSEcCtD
Glipizide—Tension—Doxorubicin—urinary bladder cancer	0.000145	0.00108	CcSEcCtD
Glipizide—Malaise—Epirubicin—urinary bladder cancer	0.000144	0.00107	CcSEcCtD
Glipizide—Discomfort—Methotrexate—urinary bladder cancer	0.000143	0.00107	CcSEcCtD
Glipizide—Nervousness—Doxorubicin—urinary bladder cancer	0.000143	0.00107	CcSEcCtD
Glipizide—Vertigo—Epirubicin—urinary bladder cancer	0.000143	0.00107	CcSEcCtD
Glipizide—Syncope—Epirubicin—urinary bladder cancer	0.000143	0.00106	CcSEcCtD
Glipizide—Leukopenia—Epirubicin—urinary bladder cancer	0.000143	0.00106	CcSEcCtD
Glipizide—PPARG—PPARA activates gene expression—CREBBP—urinary bladder cancer	0.000143	0.00356	CbGpPWpGaD
Glipizide—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000142	0.00106	CcSEcCtD
Glipizide—Confusional state—Methotrexate—urinary bladder cancer	0.00014	0.00104	CcSEcCtD
Glipizide—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00014	0.00104	CcSEcCtD
Glipizide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.00014	0.00349	CbGpPWpGaD
Glipizide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	0.00014	0.00349	CbGpPWpGaD
Glipizide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	0.00014	0.00349	CbGpPWpGaD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—EP300—urinary bladder cancer	0.000139	0.00348	CbGpPWpGaD
Glipizide—Vision blurred—Doxorubicin—urinary bladder cancer	0.000139	0.00104	CcSEcCtD
Glipizide—Nausea—Etoposide—urinary bladder cancer	0.000138	0.00103	CcSEcCtD
Glipizide—Hypertension—Epirubicin—urinary bladder cancer	0.000138	0.00103	CcSEcCtD
Glipizide—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000137	0.00343	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000137	0.00342	CbGpPWpGaD
Glipizide—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000137	0.00102	CcSEcCtD
Glipizide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000136	0.00101	CcSEcCtD
Glipizide—Arthralgia—Epirubicin—urinary bladder cancer	0.000136	0.00101	CcSEcCtD
Glipizide—Myalgia—Epirubicin—urinary bladder cancer	0.000136	0.00101	CcSEcCtD
Glipizide—Anxiety—Epirubicin—urinary bladder cancer	0.000135	0.00101	CcSEcCtD
Glipizide—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000135	0.00338	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTZ1—urinary bladder cancer	0.000135	0.00336	CbGpPWpGaD
Glipizide—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000135	0.001	CcSEcCtD
Glipizide—Discomfort—Epirubicin—urinary bladder cancer	0.000134	0.000999	CcSEcCtD
Glipizide—Malaise—Doxorubicin—urinary bladder cancer	0.000133	0.000991	CcSEcCtD
Glipizide—Vertigo—Doxorubicin—urinary bladder cancer	0.000133	0.000987	CcSEcCtD
Glipizide—Anorexia—Methotrexate—urinary bladder cancer	0.000133	0.000987	CcSEcCtD
Glipizide—Syncope—Doxorubicin—urinary bladder cancer	0.000132	0.000985	CcSEcCtD
Glipizide—Leukopenia—Doxorubicin—urinary bladder cancer	0.000132	0.000983	CcSEcCtD
Glipizide—Confusional state—Epirubicin—urinary bladder cancer	0.000131	0.000977	CcSEcCtD
Glipizide—KCNJ11—Metabolism—GSTZ1—urinary bladder cancer	0.000131	0.00326	CbGpPWpGaD
Glipizide—Oedema—Epirubicin—urinary bladder cancer	0.00013	0.000969	CcSEcCtD
Glipizide—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.00013	0.00325	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.00013	0.00325	CbGpPWpGaD
Glipizide—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00013	0.000966	CcSEcCtD
Glipizide—PPARG—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000129	0.00323	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—urinary bladder cancer	0.000129	0.00323	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000128	0.0032	CbGpPWpGaD
Glipizide—Shock—Epirubicin—urinary bladder cancer	0.000128	0.000953	CcSEcCtD
Glipizide—PPARG—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000128	0.00319	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTO2—urinary bladder cancer	0.000128	0.00319	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NAT1—urinary bladder cancer	0.000128	0.00319	CbGpPWpGaD
Glipizide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000128	0.000949	CcSEcCtD
Glipizide—Hypertension—Doxorubicin—urinary bladder cancer	0.000127	0.000948	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000127	0.000943	CcSEcCtD
Glipizide—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000126	0.000937	CcSEcCtD
Glipizide—Insomnia—Methotrexate—urinary bladder cancer	0.000126	0.000937	CcSEcCtD
Glipizide—Arthralgia—Doxorubicin—urinary bladder cancer	0.000126	0.000935	CcSEcCtD
Glipizide—Myalgia—Doxorubicin—urinary bladder cancer	0.000126	0.000935	CcSEcCtD
Glipizide—Anxiety—Doxorubicin—urinary bladder cancer	0.000125	0.000932	CcSEcCtD
Glipizide—Paraesthesia—Methotrexate—urinary bladder cancer	0.000125	0.00093	CcSEcCtD
Glipizide—PPARG—Adipogenesis—RB1—urinary bladder cancer	0.000124	0.0031	CbGpPWpGaD
Glipizide—Discomfort—Doxorubicin—urinary bladder cancer	0.000124	0.000924	CcSEcCtD
Glipizide—Anorexia—Epirubicin—urinary bladder cancer	0.000124	0.000924	CcSEcCtD
Glipizide—Dyspnoea—Methotrexate—urinary bladder cancer	0.000124	0.000923	CcSEcCtD
Glipizide—KCNJ11—Metabolism—GSTO2—urinary bladder cancer	0.000124	0.00309	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NAT1—urinary bladder cancer	0.000124	0.00309	CbGpPWpGaD
Glipizide—Somnolence—Methotrexate—urinary bladder cancer	0.000124	0.000921	CcSEcCtD
Glipizide—PPARG—Adipogenesis—IGF1—urinary bladder cancer	0.000123	0.00308	CbGpPWpGaD
Glipizide—Dyspepsia—Methotrexate—urinary bladder cancer	0.000123	0.000911	CcSEcCtD
Glipizide—Confusional state—Doxorubicin—urinary bladder cancer	0.000122	0.000904	CcSEcCtD
Glipizide—Decreased appetite—Methotrexate—urinary bladder cancer	0.000121	0.0009	CcSEcCtD
Glipizide—Oedema—Doxorubicin—urinary bladder cancer	0.000121	0.000897	CcSEcCtD
Glipizide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00012	0.000894	CcSEcCtD
Glipizide—Pain—Methotrexate—urinary bladder cancer	0.000119	0.000885	CcSEcCtD
Glipizide—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000119	0.00297	CbGpPWpGaD
Glipizide—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000119	0.000883	CcSEcCtD
Glipizide—Shock—Doxorubicin—urinary bladder cancer	0.000119	0.000882	CcSEcCtD
Glipizide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000118	0.000878	CcSEcCtD
Glipizide—Insomnia—Epirubicin—urinary bladder cancer	0.000118	0.000876	CcSEcCtD
Glipizide—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000117	0.00293	CbGpPWpGaD
Glipizide—Paraesthesia—Epirubicin—urinary bladder cancer	0.000117	0.00087	CcSEcCtD
Glipizide—ABCC8—Metabolism—UGT2B7—urinary bladder cancer	0.000117	0.00292	CbGpPWpGaD
Glipizide—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000117	0.000867	CcSEcCtD
Glipizide—Dyspnoea—Epirubicin—urinary bladder cancer	0.000116	0.000864	CcSEcCtD
Glipizide—Somnolence—Epirubicin—urinary bladder cancer	0.000116	0.000861	CcSEcCtD
Glipizide—Anorexia—Doxorubicin—urinary bladder cancer	0.000115	0.000855	CcSEcCtD
Glipizide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000115	0.000853	CcSEcCtD
Glipizide—Dyspepsia—Epirubicin—urinary bladder cancer	0.000115	0.000853	CcSEcCtD
Glipizide—PPARG—Circadian rythm related genes—FAS—urinary bladder cancer	0.000115	0.00286	CbGpPWpGaD
Glipizide—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000114	0.000847	CcSEcCtD
Glipizide—KCNJ11—Metabolism—UGT2B7—urinary bladder cancer	0.000113	0.00283	CbGpPWpGaD
Glipizide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000113	0.000842	CcSEcCtD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—TNF—urinary bladder cancer	0.000113	0.00283	CbGpPWpGaD
Glipizide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000112	0.000837	CcSEcCtD
Glipizide—Pain—Epirubicin—urinary bladder cancer	0.000111	0.000829	CcSEcCtD
Glipizide—Constipation—Epirubicin—urinary bladder cancer	0.000111	0.000829	CcSEcCtD
Glipizide—Urticaria—Methotrexate—urinary bladder cancer	0.000111	0.000823	CcSEcCtD
Glipizide—Abdominal pain—Methotrexate—urinary bladder cancer	0.00011	0.000819	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00011	0.000817	CcSEcCtD
Glipizide—Insomnia—Doxorubicin—urinary bladder cancer	0.000109	0.000811	CcSEcCtD
Glipizide—ABCC8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000109	0.00271	CbGpPWpGaD
Glipizide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000108	0.000805	CcSEcCtD
Glipizide—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000108	0.0027	CbGpPWpGaD
Glipizide—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000107	0.000799	CcSEcCtD
Glipizide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000107	0.000799	CcSEcCtD
Glipizide—Somnolence—Doxorubicin—urinary bladder cancer	0.000107	0.000797	CcSEcCtD
Glipizide—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000107	0.00267	CbGpPWpGaD
Glipizide—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000107	0.000792	CcSEcCtD
Glipizide—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000106	0.00266	CbGpPWpGaD
Glipizide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000106	0.000789	CcSEcCtD
Glipizide—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000106	0.00264	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP4B1—urinary bladder cancer	0.000105	0.00263	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—urinary bladder cancer	0.000105	0.00262	CbGpPWpGaD
Glipizide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000105	0.000779	CcSEcCtD
Glipizide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000104	0.000774	CcSEcCtD
Glipizide—Urticaria—Epirubicin—urinary bladder cancer	0.000103	0.00077	CcSEcCtD
Glipizide—Constipation—Doxorubicin—urinary bladder cancer	0.000103	0.000767	CcSEcCtD
Glipizide—Pain—Doxorubicin—urinary bladder cancer	0.000103	0.000767	CcSEcCtD
Glipizide—Abdominal pain—Epirubicin—urinary bladder cancer	0.000103	0.000766	CcSEcCtD
Glipizide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000103	0.000763	CcSEcCtD
Glipizide—KCNJ11—Metabolism—CYP4B1—urinary bladder cancer	0.000102	0.00255	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000101	0.00252	CbGpPWpGaD
Glipizide—Asthenia—Methotrexate—urinary bladder cancer	9.99e-05	0.000743	CcSEcCtD
Glipizide—Feeling abnormal—Doxorubicin—urinary bladder cancer	9.93e-05	0.000739	CcSEcCtD
Glipizide—ABCC8—Metabolism—SLC19A1—urinary bladder cancer	9.93e-05	0.00248	CbGpPWpGaD
Glipizide—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	9.85e-05	0.000733	CcSEcCtD
Glipizide—Pruritus—Methotrexate—urinary bladder cancer	9.85e-05	0.000733	CcSEcCtD
Glipizide—PPARG—PPARA activates gene expression—EP300—urinary bladder cancer	9.71e-05	0.00243	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PRSS3—urinary bladder cancer	9.68e-05	0.00242	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTZ1—urinary bladder cancer	9.65e-05	0.00241	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—SLC19A1—urinary bladder cancer	9.63e-05	0.00241	CbGpPWpGaD
Glipizide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	9.61e-05	0.0024	CbGpPWpGaD
Glipizide—Hypersensitivity—Epirubicin—urinary bladder cancer	9.6e-05	0.000714	CcSEcCtD
Glipizide—Urticaria—Doxorubicin—urinary bladder cancer	9.57e-05	0.000712	CcSEcCtD
Glipizide—Abdominal pain—Doxorubicin—urinary bladder cancer	9.53e-05	0.000709	CcSEcCtD
Glipizide—Diarrhoea—Methotrexate—urinary bladder cancer	9.52e-05	0.000708	CcSEcCtD
Glipizide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	9.5e-05	0.00237	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PRSS3—urinary bladder cancer	9.38e-05	0.00234	CbGpPWpGaD
Glipizide—Asthenia—Epirubicin—urinary bladder cancer	9.34e-05	0.000695	CcSEcCtD
Glipizide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	9.22e-05	0.0023	CbGpPWpGaD
Glipizide—Pruritus—Epirubicin—urinary bladder cancer	9.21e-05	0.000686	CcSEcCtD
Glipizide—Dizziness—Methotrexate—urinary bladder cancer	9.2e-05	0.000685	CcSEcCtD
Glipizide—PPARG—Metabolism—GSTO2—urinary bladder cancer	9.15e-05	0.00229	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NAT1—urinary bladder cancer	9.15e-05	0.00229	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9e-05	0.00225	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—CDKN1A—urinary bladder cancer	8.93e-05	0.00223	CbGpPWpGaD
Glipizide—Diarrhoea—Epirubicin—urinary bladder cancer	8.91e-05	0.000663	CcSEcCtD
Glipizide—Hypersensitivity—Doxorubicin—urinary bladder cancer	8.88e-05	0.000661	CcSEcCtD
Glipizide—Vomiting—Methotrexate—urinary bladder cancer	8.85e-05	0.000658	CcSEcCtD
Glipizide—Rash—Methotrexate—urinary bladder cancer	8.78e-05	0.000653	CcSEcCtD
Glipizide—Dermatitis—Methotrexate—urinary bladder cancer	8.77e-05	0.000652	CcSEcCtD
Glipizide—Headache—Methotrexate—urinary bladder cancer	8.72e-05	0.000649	CcSEcCtD
Glipizide—Asthenia—Doxorubicin—urinary bladder cancer	8.65e-05	0.000643	CcSEcCtD
Glipizide—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	8.63e-05	0.00216	CbGpPWpGaD
Glipizide—Dizziness—Epirubicin—urinary bladder cancer	8.61e-05	0.000641	CcSEcCtD
Glipizide—PPARG—Generic Transcription Pathway—ESR2—urinary bladder cancer	8.57e-05	0.00214	CbGpPWpGaD
Glipizide—Pruritus—Doxorubicin—urinary bladder cancer	8.53e-05	0.000634	CcSEcCtD
Glipizide—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	8.37e-05	0.00209	CbGpPWpGaD
Glipizide—PPARG—Metabolism—UGT2B7—urinary bladder cancer	8.37e-05	0.00209	CbGpPWpGaD
Glipizide—Vomiting—Epirubicin—urinary bladder cancer	8.28e-05	0.000616	CcSEcCtD
Glipizide—Nausea—Methotrexate—urinary bladder cancer	8.27e-05	0.000615	CcSEcCtD
Glipizide—Diarrhoea—Doxorubicin—urinary bladder cancer	8.25e-05	0.000613	CcSEcCtD
Glipizide—Rash—Epirubicin—urinary bladder cancer	8.21e-05	0.000611	CcSEcCtD
Glipizide—Dermatitis—Epirubicin—urinary bladder cancer	8.2e-05	0.00061	CcSEcCtD
Glipizide—Headache—Epirubicin—urinary bladder cancer	8.16e-05	0.000607	CcSEcCtD
Glipizide—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	8.08e-05	0.00202	CbGpPWpGaD
Glipizide—Dizziness—Doxorubicin—urinary bladder cancer	7.97e-05	0.000593	CcSEcCtD
Glipizide—ABCC8—Metabolism—TYMP—urinary bladder cancer	7.74e-05	0.00193	CbGpPWpGaD
Glipizide—Nausea—Epirubicin—urinary bladder cancer	7.74e-05	0.000576	CcSEcCtD
Glipizide—Vomiting—Doxorubicin—urinary bladder cancer	7.66e-05	0.00057	CcSEcCtD
Glipizide—Rash—Doxorubicin—urinary bladder cancer	7.6e-05	0.000565	CcSEcCtD
Glipizide—Dermatitis—Doxorubicin—urinary bladder cancer	7.59e-05	0.000565	CcSEcCtD
Glipizide—Headache—Doxorubicin—urinary bladder cancer	7.55e-05	0.000562	CcSEcCtD
Glipizide—PPARG—Metabolism—CYP4B1—urinary bladder cancer	7.54e-05	0.00188	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—TYMP—urinary bladder cancer	7.5e-05	0.00187	CbGpPWpGaD
Glipizide—Nausea—Doxorubicin—urinary bladder cancer	7.16e-05	0.000533	CcSEcCtD
Glipizide—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	7.12e-05	0.00178	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SLC19A1—urinary bladder cancer	7.12e-05	0.00178	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	7.02e-05	0.00175	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NAT2—urinary bladder cancer	7e-05	0.00175	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PRSS3—urinary bladder cancer	6.94e-05	0.00173	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—TNF—urinary bladder cancer	6.89e-05	0.00172	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NAT2—urinary bladder cancer	6.78e-05	0.00169	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—NCOR1—urinary bladder cancer	6.62e-05	0.00165	CbGpPWpGaD
Glipizide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	6.55e-05	0.00164	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—PTEN—urinary bladder cancer	6.29e-05	0.00157	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	6.23e-05	0.00156	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NCOR1—urinary bladder cancer	6.23e-05	0.00156	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—RRM2—urinary bladder cancer	6.04e-05	0.00151	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—EP300—urinary bladder cancer	5.99e-05	0.0015	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—RRM2—urinary bladder cancer	5.86e-05	0.00146	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	5.8e-05	0.00145	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.72e-05	0.00143	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	5.69e-05	0.00142	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—HPGDS—urinary bladder cancer	5.59e-05	0.0014	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ENO2—urinary bladder cancer	5.59e-05	0.0014	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.56e-05	0.00139	CbGpPWpGaD
Glipizide—PPARG—Metabolism—TYMP—urinary bladder cancer	5.54e-05	0.00138	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	5.52e-05	0.00138	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTT1—urinary bladder cancer	5.43e-05	0.00136	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ENO2—urinary bladder cancer	5.42e-05	0.00135	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—HPGDS—urinary bladder cancer	5.42e-05	0.00135	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	5.33e-05	0.00133	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.33e-05	0.00133	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTT1—urinary bladder cancer	5.26e-05	0.00131	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.26e-05	0.00131	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—ESR1—urinary bladder cancer	5.2e-05	0.0013	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.08e-05	0.00127	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NAT2—urinary bladder cancer	5.01e-05	0.00125	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CDK4—urinary bladder cancer	4.91e-05	0.00123	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SMC1A—urinary bladder cancer	4.73e-05	0.00118	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—CREBBP—urinary bladder cancer	4.55e-05	0.00114	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NQO1—urinary bladder cancer	4.51e-05	0.00113	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—HRAS—urinary bladder cancer	4.4e-05	0.0011	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NQO1—urinary bladder cancer	4.37e-05	0.00109	CbGpPWpGaD
Glipizide—PPARG—Metabolism—RRM2—urinary bladder cancer	4.33e-05	0.00108	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TP53—urinary bladder cancer	4.29e-05	0.00107	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CREBBP—urinary bladder cancer	4.29e-05	0.00107	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—HRAS—urinary bladder cancer	4.27e-05	0.00107	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ESR2—urinary bladder cancer	4.13e-05	0.00103	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HPGDS—urinary bladder cancer	4.01e-05	0.001	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ENO2—urinary bladder cancer	4.01e-05	0.001	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTT1—urinary bladder cancer	3.89e-05	0.000971	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—RHOA—urinary bladder cancer	3.88e-05	0.000969	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.83e-05	0.000956	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	3.83e-05	0.000956	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.77e-05	0.000943	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTP1—urinary bladder cancer	3.76e-05	0.000939	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTP1—urinary bladder cancer	3.65e-05	0.000911	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ERBB2—urinary bladder cancer	3.59e-05	0.000897	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	3.56e-05	0.000888	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	3.52e-05	0.000879	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—TYMS—urinary bladder cancer	3.5e-05	0.000873	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.47e-05	0.000866	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTM1—urinary bladder cancer	3.46e-05	0.000863	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NCOR1—urinary bladder cancer	3.46e-05	0.000863	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—TYMS—urinary bladder cancer	3.39e-05	0.000847	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	3.37e-05	0.000842	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NAT1—urinary bladder cancer	3.37e-05	0.000842	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTM1—urinary bladder cancer	3.35e-05	0.000837	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NCOR1—urinary bladder cancer	3.35e-05	0.000837	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.31e-05	0.000828	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GPX1—urinary bladder cancer	3.31e-05	0.000827	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ERCC2—urinary bladder cancer	3.25e-05	0.000812	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NQO1—urinary bladder cancer	3.23e-05	0.000807	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GPX1—urinary bladder cancer	3.21e-05	0.000802	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NCOR1—urinary bladder cancer	3.18e-05	0.000796	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ERCC2—urinary bladder cancer	3.15e-05	0.000787	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.13e-05	0.000783	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	3.08e-05	0.00077	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP9—urinary bladder cancer	3.08e-05	0.000769	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—MTHFR—urinary bladder cancer	3.05e-05	0.000763	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ERCC2—urinary bladder cancer	2.99e-05	0.000748	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—MTHFR—urinary bladder cancer	2.96e-05	0.00074	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EP300—urinary bladder cancer	2.92e-05	0.000729	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—SRC—urinary bladder cancer	2.84e-05	0.000709	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	2.78e-05	0.000693	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.73e-05	0.000683	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—MYC—urinary bladder cancer	2.7e-05	0.000675	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTP1—urinary bladder cancer	2.69e-05	0.000673	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	2.62e-05	0.000655	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.61e-05	0.000651	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	2.55e-05	0.000638	CbGpPWpGaD
Glipizide—PPARG—Metabolism—TYMS—urinary bladder cancer	2.51e-05	0.000626	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ESR1—urinary bladder cancer	2.5e-05	0.000625	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EGFR—urinary bladder cancer	2.49e-05	0.000622	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NCOR1—urinary bladder cancer	2.48e-05	0.000619	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTM1—urinary bladder cancer	2.48e-05	0.000619	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARG—urinary bladder cancer	2.48e-05	0.000619	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARG—urinary bladder cancer	2.4e-05	0.0006	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CREBBP—urinary bladder cancer	2.38e-05	0.000594	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GPX1—urinary bladder cancer	2.37e-05	0.000592	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—urinary bladder cancer	2.37e-05	0.000592	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KRAS—urinary bladder cancer	2.35e-05	0.000587	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.34e-05	0.000586	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ERCC2—urinary bladder cancer	2.33e-05	0.000582	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CREBBP—urinary bladder cancer	2.31e-05	0.000576	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.22e-05	0.000555	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.22e-05	0.000555	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—CREBBP—urinary bladder cancer	2.19e-05	0.000548	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MTHFR—urinary bladder cancer	2.19e-05	0.000547	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.05e-05	0.000512	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.04e-05	0.00051	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.03e-05	0.000508	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—HRAS—urinary bladder cancer	2e-05	0.000499	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.96e-05	0.00049	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—urinary bladder cancer	1.95e-05	0.000487	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—urinary bladder cancer	1.89e-05	0.000472	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.85e-05	0.000461	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.83e-05	0.000457	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.73e-05	0.000432	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CREBBP—urinary bladder cancer	1.7e-05	0.000426	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTEN—urinary bladder cancer	1.7e-05	0.000424	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.68e-05	0.000421	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTEN—urinary bladder cancer	1.65e-05	0.000412	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—EP300—urinary bladder cancer	1.62e-05	0.000405	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.59e-05	0.000398	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—EP300—urinary bladder cancer	1.57e-05	0.000392	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.48e-05	0.000369	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.48e-05	0.000369	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.47e-05	0.000367	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.43e-05	0.000358	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.41e-05	0.000352	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—urinary bladder cancer	1.4e-05	0.000349	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.35e-05	0.000336	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MYC—urinary bladder cancer	1.3e-05	0.000325	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.22e-05	0.000304	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTEN—urinary bladder cancer	1.22e-05	0.000304	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.19e-05	0.000297	CbGpPWpGaD
Glipizide—PPARG—Metabolism—EP300—urinary bladder cancer	1.16e-05	0.00029	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.15e-05	0.000288	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.05e-05	0.000263	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.01e-05	0.000251	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	9.92e-06	0.000248	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ENO2—urinary bladder cancer	9.74e-06	0.000243	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	9.74e-06	0.000243	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.6e-06	0.00024	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	9.44e-06	0.000236	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TYMS—urinary bladder cancer	9.23e-06	0.00023	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	9.12e-06	0.000228	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	9.12e-06	0.000228	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPX1—urinary bladder cancer	8.73e-06	0.000218	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	8.57e-06	0.000214	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	8.06e-06	0.000201	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NQO1—urinary bladder cancer	7.85e-06	0.000196	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	6.55e-06	0.000163	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARG—urinary bladder cancer	6.54e-06	0.000163	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	6.28e-06	0.000157	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TYMS—urinary bladder cancer	6.08e-06	0.000152	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	6.01e-06	0.00015	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	6.01e-06	0.00015	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.76e-06	0.000144	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.66e-06	0.000141	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.32e-06	0.000133	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	5.14e-06	0.000128	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTEN—urinary bladder cancer	4.48e-06	0.000112	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.31e-06	0.000108	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—EP300—urinary bladder cancer	4.28e-06	0.000107	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.14e-06	0.000103	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.39e-06	8.47e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.96e-06	7.39e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.82e-06	7.04e-05	CbGpPWpGaD
